Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-05-23 @ 7:00 AM
Study NCT ID:
NCT06662994
Status:
RECRUITING
Last Update Posted:
2025-07-10
First Post:
2024-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Sponsor:
Retina Consultants of Orange County
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetic Macular Edema (DME) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | diabetic macular edema | View |
| None | diabetes | View |
| None | type 1 diabetes | View |
| None | type 2 diabetes | View |
| None | Diabetic Retinopathy | View |
| None | anti-VEGF | View |
| None | aflibercept | View |
| None | aflibercept 8 mg | View |
| None | vitrectomy | View |
| None | proliferative diabetic retinopathy | View |
| None | non-proliferative diabetic retinopathy | View |